Related Experiment Video
Updated: Jun 26, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Transfusions in burn patients with/without comorbidities.
Leonard Boral1, Areta Kowal-Vern, Mariano Yogore
1Department of Pathology, University of Kentucky Medical Center, Lexington, Kentucky, USA.
Burn patients with medical comorbidities, especially those with cardiac or cerebrovascular conditions, are more likely to require blood transfusions. Transfusions in these patients correlate with increased mortality risk.
Area of Science:
- Medical research
- Burn care
- Transfusion medicine
Background:
- Medical comorbidities are established risk factors for mortality in burn patients.
- Large burn injuries frequently necessitate blood transfusions during surgical procedures like excision and skin grafting.
Purpose of the Study:
- To investigate differences in blood transfusion requirements between burn patients with and without comorbid medical conditions.
- To identify specific comorbidities and injury characteristics associated with increased transfusion likelihood.
Main Methods:
- Retrospective review of 1,490 burn patient admissions between March 1999 and May 2004.
- Analysis of comorbidity data, transfusion status, total body surface area (TBSA) burn percentage, surgical procedures, and mortality.
- Statistical comparison of transfusion rates and outcomes between patients with and without comorbidities.
Main Results:
- 26% of burn patients (383/1,490) had comorbidities. Of these, 22% (85/383) received transfusions.
- Patients with comorbidities who received transfusions had significantly larger burn sizes (19% TBSA) and longer hospital stays (29 days) compared to non-transfused patients with comorbidities (8% TBSA, 8 days).
- Cardiac diseases, stroke, and CNS/psychiatric disorders increased the odds of transfusion. Procedures and inhalation injuries also elevated transfusion likelihood.
Conclusions:
- Burn patients with comorbidities are more prone to requiring blood transfusions, even with smaller burn sizes (<20% TBSA).
- Transfused burn patients with comorbidities face a significantly higher mortality risk (5-fold increase).
- Identifying and managing comorbidities is crucial for optimizing transfusion strategies and improving outcomes in burn care.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
